Product Overview
The SCYLLA™ cellular bone matrices are viable allogeneic bone allografts containing viable bone-derived cells. Each SCYLLA™ product contains the three key components that are ideal for bone formation:
-An osteoconductive three-dimensional scaffold with cortical and cancellous components
-A demineralized bone scaffold with osteoinductive potential, which provides exposure of signaling molecules and bone morphogenetic proteins1
-Bone-derived cells to support osteogenic healing processes
Key Features of SCYLLA™ Product Line
-Three (3) unique scaffold blends for optimal handling
characteristics: SCYLLA™, SCYLLA™ Moldable,
SCYLLA™-F Moldable.
-Proprietary, optimized bone microparticulate size
range of 100-300 μm.
-Novel DMSO-free cryoprotectant, with no rinsing and
decanting steps required prior to use.
-Average cell viability of the cell component exceeds
80% post-thaw.
-Minimum of 150,000 viable cells per cc of allograft
post-thaw.
-Convenient handling and preparation in the OR, with
total preparation time on the back table of less than
20 minutes.
-Four (4) hour working window for implantation after
thaw without loss of cell viability.
-Product shelf-life is two (2) years from date of
processing when stored at -65°C or colder.
https://www.cambermedtech.com/scylla-cellular-bone-matrix
